China said Monday its launch of a new spacecraft was merely a test to see whether the vehicle could be re-used.

Foreign Ministry spokesperson Zhao Lijian said the launch involved a spacecraft rather than a missile and was of “great significance for reducing the use-cost of spacecraft and could provide a convenient and affordable way to make a round trip for mankind’s peaceful use of space.”

China’s space program is run by its military and is closely tied to its agenda of building hypersonic missiles and other technologies that could alter the balance of power with the United States.

“China will work together with other countries in the world for the peaceful use of space and the benefit of mankind," Zhao said.

Zhao's comments on the August test came days after China launched a second three-person crew to staff its space station on a six-month mission.

Alongside its space program, China's expansion into hypersonic missile technology and other advanced fields has raised concerns as Beijing becomes increasingly assertive over its claims to seas and islands in the South China and East China Seas and to large chunks of territory along its disputed high-mountain border with India.

Japan, one of China's chief regional rivals, said it would boost its defenses against what it interpreted as a new offensive Chinese weapon.

Chief Cabinet Secretary Hirokazu Matsuno on Monday called it a “new threat” that conventional equipment would have difficulty dealing with. He said Japan will step up its detection, tracking and shooting-down capability of “any aerial threat.”

China appears to be rapidly pushing development of hypersonic nuclear weapons to gain strike capability that can break through missile defenses, Matsuno said.

He criticized China for increasing its defense spending, particularly for nuclear and missile capabilities, without explaining its intentions.

“China’s rapidly expanding and increased military activity at sea and airspace has become a strong security concern for the region including Japan and the international society,” Matsuno said.

___

Associated Press writer Mari Yamaguchi in Tokyo contributed to this report.

Share:
More In Politics
Trump suggests canceling Xi meeting and threatens more tariffs after China restricts key exports
President Donald Trump says “there seems to be no reason” to meet with Chinese leader Xi Jinping as part of an upcoming trip to South Korea after China restricted exports of rare earths needed for American industry. The Republican president suggested Friday he was looking at a “massive increase” of import taxes on Chinese products in response to Xi’s moves. Trump says one of the policies the U.S. is calculating is "a massive increase of Tariffs on Chinese products coming into the United States." A monthslong calm on Wall Street was shattered, with U.S. stocks falling on the news. The Chinese Embassy in Washington hasn't responded to an Associated Press request for comment.
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More